Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EksoNR

K-Number: K200574 · 2020-06-19

Decision Date2020-06-19
Product CodePHL
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

EksoNR is a medical device manufactured by Ekso Bionics, Inc.. It received FDA 510(k) clearance on 2020-06-19 under approval number K200574. The device is classified under product code PHL. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EksoNR?

EksoNR is a medical device that received FDA 510(k) clearance on 2020-06-19. It is manufactured by Ekso Bionics, Inc.. The 510(k) number is K200574.

When was EksoNR approved by the FDA?

EksoNR received FDA 510(k) clearance on 2020-06-19, under approval number K200574.

What company makes EksoNR?

EksoNR is manufactured by Ekso Bionics, Inc..

What is the FDA product code for EksoNR?

The FDA product code for EksoNR is PHL.

Other Devices by Ekso Bionics, Inc.

Related Devices (Code: PHL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.